A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to Hypoglycemia

Phase 1 study, condition: Type 2 Diabetes Mellitus. The purpose of this study is to measure the effect of retatrutide versus placebo, administered every week, on time to recovery from hypoglycemia during hypoglycemic clamp in participants with Type 2 Diabetes Mellitus (T2DM) following 16 weeks of treatment. Enrolment: 80 participants. Status: completed. No topline or peer-reviewed results are verified for publication on this Record for this study — registry facts only.